MAMMALIAN PHENOTYPE - ANNOTATIONS
The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.
Term: reproductive system phenotype
Accession: MP:0005389
browse the term
Definition: the observable morphological and physiological characteristics of the mammalian organs associated with producing offspring that are manifested through development and lifespan
Synonyms: exact_synonym: reproduction phenotype
narrow_synonym: Abnormality of the genital system
xref: HP:0000078
G
Dhh
desert hedgehog signaling molecule
IMP
RGD
PMID:21062903
RGD:38548923
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
G
Egfr
epidermal growth factor receptor
IDA
RGD
PMID:11796513
RGD:70386
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Inha
inhibin subunit alpha
IDA
rat transgene introduced into female mice
RGD
PMID:15359127
RGD:2290396
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:24506075
RGD:8552987
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr1em1Soar
estrogen receptor 1; ZFN induced mutant 1, Soar
IMP
RGD
PMID:24506075
RGD:8552987
G
Dhh
desert hedgehog signaling molecule
IMP
RGD
PMID:21062903
RGD:38548923
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
G
Wwox
WW domain-containing oxidoreductase
IAGP
DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 compared to wild type and heterozygotes
RGD
PMID:19500159 PMID:17803050 PMID:18676360
RGD:150429979 , RGD:150429978 , RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360 PMID:19500159 PMID:17803050
RGD:150429974 , RGD:150429979 , RGD:150429978
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:24506075
RGD:8552987
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr1em1Soar
estrogen receptor 1; ZFN induced mutant 1, Soar
IMP
RGD
PMID:24506075
RGD:8552987
G
Spata22
spermatogenesis associated 22
treatment
IDA
RGD
PMID:23903057
RGD:38549346
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
G
Atm
ATM serine/threonine kinase
IMP
DNA:deletion:exon:
RGD
PMID:27895165 PMID:28007901
RGD:12879393 , RGD:12879399
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atmem1Kyo
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo
IMP
RGD
PMID:28007901
RGD:12879399
G
Atmm1Kyo
ATM serine/threonine kinase; ENU induced mutant 1, Kyo
IMP
RGD
PMID:27895165
RGD:12879393
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:28520870
RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
RGD
PMID:28520870
RGD:38548924
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:24506075
RGD:8552987
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Mecp2
methyl CpG binding protein 2
IMP
compared to SD wild-type male
RGD
PMID:27329765
RGD:40924662
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mecp2em1Sage
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs
IMP
compared to SD wild-type male
RGD
PMID:27329765
RGD:40924662
G
Atm
ATM serine/threonine kinase
IMP
DNA:deletion:exon:
RGD
PMID:27895165 PMID:28007901
RGD:12879393 , RGD:12879399
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atmem1Kyo
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo
IMP
RGD
PMID:28007901
RGD:12879399
G
Atmm1Kyo
ATM serine/threonine kinase; ENU induced mutant 1, Kyo
IMP
RGD
PMID:27895165
RGD:12879393
G
Brca2
BRCA2, DNA repair associated
IAGP IMP
RGD
PMID:16964288 PMID:16964288
RGD:1599505 , RGD:1599505
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brca2m1Uwm
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison
IMP
RGD
PMID:16964288
RGD:1599505
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Il15
interleukin 15
IMP
RGD
PMID:28395334
RGD:12910490
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il15em1Soar
interleukin 15; ZFN induced mutant 1, Soar
IMP
RGD
PMID:28395334
RGD:12910490
G
Mmp12
matrix metallopeptidase 12
IMP
RGD
PMID:27807143
RGD:12910498
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:28520870 PMID:29580824
RGD:38548924 , RGD:38548925
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
RGD
PMID:28520870 PMID:29580824
RGD:38548924 , RGD:38548925
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Esr2
estrogen receptor 2
IMP
compared to wild type
RGD
PMID:28520870
RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
compared to wild type
RGD
PMID:28520870
RGD:38548924
G
Kiss1
KiSS-1 metastasis-suppressor
IMP
RGD
PMID:25582792
RGD:10059342
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
G
Kiss1tm1Nips
KiSS-1 metastasis-suppressor; targeted mutant 1, Nips
IMP
RGD
PMID:25582792
RGD:10059342
G
Cftr
CF transmembrane conductance regulator
IMP
RGD
PMID:31942562
RGD:126928119
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Cftrem2Ang
cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang
IMP
RGD
PMID:31942562
RGD:126928119
G
Esr2
estrogen receptor 2
IMP
compared to wild type
RGD
PMID:29580824 PMID:28520870
RGD:38548925 , RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
compared to wild type
RGD
PMID:29580824 PMID:28520870
RGD:38548925 , RGD:38548924
G
Sbf1
SET binding factor 1
IAGP
DNA:substitution:intron 37:G>A (rat)
RGD
PMID:27335132
RGD:38549340
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
G
Sbf1m1Ipcv
SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences
IAGP
RGD
PMID:27335132
RGD:38549340
G
Spata22
spermatogenesis associated 22
treatment
IDA
RGD
PMID:23903057
RGD:38549346
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
G
Sbf1
SET binding factor 1
IAGP
DNA:substitution:intron 37:G>A (rat)
RGD
PMID:27335132
RGD:38549340
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
G
Sbf1m1Ipcv
SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences
IAGP
RGD
PMID:27335132
RGD:38549340
G
Csf1r
colony stimulating factor 1 receptor
IMP
RGD
PMID:30249809
RGD:41404725
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf1rtm(EGFP)Tset
colony stimulating factor 1 receptor; target mutant, Tset
IMP
RGD
PMID:30249809
RGD:41404725
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Acr
acrosin
IMP
RGD
PMID:28859281
RGD:13464336
NCBI chr 7:120,636,581...120,644,474
Ensembl chr 7:120,638,321...120,644,474
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
IMP
compared to wild type
RGD
PMID:29444903
RGD:150429710
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c11em1Nju
cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju
IMP
compared to wild type
RGD
PMID:29444903
RGD:150429710
G
Defb23em2Mlit Defb26em2Mlit
defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit
IMP
RGD
PMID:29141997
RGD:13782190
G
Fh
fumarate hydratase
IMP
RGD
PMID:27556703
RGD:13792708
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
G
Fhem1
fumarate hydratase; TALEN induced mutant 1
IMP
RGD
PMID:27556703
RGD:13792708
G
Mmp12
matrix metallopeptidase 12
IMP
RGD
PMID:27807143
RGD:12910498
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp12em2Soar
matrix metallopeptidase 12; TALEN induced mutant 2,Soar
IMP
RGD
PMID:27807143
RGD:12910498
G
Nkx3-1
NK3 homeobox 1
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nkx3-1em1Pjhak
NK3 homeobox 1; TALEN induced mutant 1, Pjhak
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
G
Ahr
aryl hydrocarbon receptor
IMP
compared to Hsd:SD
RGD
PMID:23859880
RGD:13204753
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahrem2Sage
aryl hydrocarbon receptor; ZFN induced mutant2, Sage
IMP
compared to Hsd:SD
RGD
PMID:23859880
RGD:13204753
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:29580824 PMID:28520870
RGD:38548925 , RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
compared to wild type
RGD
PMID:28520870 PMID:29580824
RGD:38548924 , RGD:38548925
G
Nkx3-1
NK3 homeobox 1
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nkx3-1em1Pjhak
NK3 homeobox 1; TALEN induced mutant 1, Pjhak
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Defb23em2Mlit Defb26em2Mlit
defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit
IMP
RGD
PMID:29141997
RGD:13782190
G
Ahr
aryl hydrocarbon receptor
IMP
compared to Hsd:SD
RGD
PMID:23859880
RGD:13204753
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahrem2Sage
aryl hydrocarbon receptor; ZFN induced mutant2, Sage
IMP
compared to Hsd:SD
RGD
PMID:23859880
RGD:13204753
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
IMP
RGD
PMID:25934999
RGD:11085488
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Bscl2m1Kyo
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo
IMP
RGD
PMID:25934999
RGD:11085488
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY and heterozygous
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY and heterozygous
RGD
PMID:22655094
RGD:40924659
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:24506075
RGD:8552987
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr1em1Soar
estrogen receptor 1; ZFN induced mutant 1, Soar
IMP
RGD
PMID:24506075
RGD:8552987
G
Sbf1
SET binding factor 1
IAGP
DNA:substitution:intron 37:G>A (rat)
RGD
PMID:27335132
RGD:38549340
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
G
Sbf1m1Ipcv
SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences
IAGP
RGD
PMID:27335132
RGD:38549340
G
Spata22
spermatogenesis associated 22
treatment
IDA
RGD
PMID:23903057
RGD:38549346
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
G
Tp53
tumor protein p53
IMP
RGD
PMID:28834365
RGD:14995504
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53em1Sage
tumor protein p53; ZFN induced mutant 1, Sage
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360 PMID:17803050
RGD:150429974 , RGD:150429978
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360 PMID:17803050
RGD:150429974 , RGD:150429978
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:28520870
RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
RGD
PMID:28520870
RGD:38548924
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
IMP
compared to wild type
RGD
PMID:29444903
RGD:150429710
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c11em1Nju
cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju
IMP
compared to wild type
RGD
PMID:29444903
RGD:150429710
G
Kiss1
KiSS-1 metastasis-suppressor
IDA
via chronic central administration of kisspeptin-10 to immature females
RGD
PMID:15486019
RGD:2292180
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
G
Fmr1
fragile X messenger ribonucleoprotein 1
IMP
DNA:deletion:intron 7, exon 8:
RGD
PMID:24773431 PMID:30877790 PMID:28894415
RGD:9831152 , RGD:38548928 , RGD:38501107
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
G
Fmr1em1Mzhe
FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe
IMP
RGD
PMID:28894415
RGD:38501107
G
Fmr1em1Sage
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs
IMP
DNA:deletion:intron 7, exon 8:
RGD
PMID:24773431 PMID:30877790
RGD:9831152 , RGD:38548928
G
Ndufc2
NADH:ubiquinone oxidoreductase subunit C2
IMP
DNA:deletion:exon1:no homozygous knockout embryos found at implantation stage
RGD
PMID:26888427
RGD:11040458
NCBI chr 1:151,711,965...151,718,188
Ensembl chr 1:151,711,901...151,718,189
G
Ndufc2em1Mcwi
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin
IMP
DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage
RGD
PMID:26888427
RGD:11040458
G
Ndufc2em2Mcwi
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
IMP
DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage
RGD
PMID:26888427
RGD:11040458
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:29580824
RGD:38548925
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
RGD
PMID:29580824
RGD:38548925
G
Acr
acrosin
IMP
RGD
PMID:28859281
RGD:13464336
NCBI chr 7:120,636,581...120,644,474
Ensembl chr 7:120,638,321...120,644,474
G
Defb23em2Mlit Defb26em2Mlit
defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit
IMP
RGD
PMID:29141997
RGD:13782190
G
Inha
inhibin subunit alpha
IDA
rat transgene introduced into female mice
RGD
PMID:15359127
RGD:2290396
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Tp53
tumor protein p53
IMP
RGD
PMID:28834365
RGD:14995504
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Ngly1
N-glycanase 1
IMP
RGD
PMID:32259258
RGD:39457703
NCBI chr15:9,153,738...9,210,228
Ensembl chr15:9,153,738...9,204,630
G
Ngly1em1Ta
N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta
IMP
RGD
PMID:32259258
RGD:39457703
G
Tshr
thyroid stimulating hormone receptor
IMP
RGD
PMID:29507327
RGD:150521601
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
G
Tshrem1Mlit
thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit
IMP
RGD
PMID:29507327
RGD:150521601
G
Sbf1
SET binding factor 1
IAGP
DNA:substitution:intron 37:G>A (rat)
RGD
PMID:27335132
RGD:38549340
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
G
Sbf1m1Ipcv
SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences
IAGP
RGD
PMID:27335132
RGD:38549340
G
Dhh
desert hedgehog signaling molecule
IMP
RGD
PMID:21062903
RGD:38548923
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
G
Brca2
BRCA2, DNA repair associated
IMP
RGD
PMID:12754522
RGD:727990
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brca2m1Uwm
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison
IMP
RGD
PMID:12754522
RGD:727990
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Spata22
spermatogenesis associated 22
treatment
IDA
RGD
PMID:23903057
RGD:38549346
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
G
Esr2
estrogen receptor 2
IMP
compared to wild type
RGD
PMID:28520870
RGD:38548924
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esr2em1Soar
estrogen receptor 2; ZFN induced mutant 1, Soar
IMP
compared to wild type
RGD
PMID:28520870
RGD:38548924
G
Mecp2
methyl CpG binding protein 2
IMP
RGD
PMID:27313794
RGD:11568037
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mecp2em1Sage
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs
IMP
RGD
PMID:27313794
RGD:11568037
G
Defb23em2Mlit Defb26em2Mlit
defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit
IMP
RGD
PMID:29141997
RGD:13782190
G
Nkx3-1
NK3 homeobox 1
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nkx3-1em1Pjhak
NK3 homeobox 1; TALEN induced mutant 1, Pjhak
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
IMP
in KO rat
RGD
PMID:30893315
RGD:126908018
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1bem1Musc
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc
IMP
RGD
PMID:30893315
RGD:126908018
G
Cdkn1bem4Musc
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc
IMP
RGD
PMID:30893315
RGD:126908018
G
Bckdk
branched chain ketoacid dehydrogenase kinase
IAGP
DNA:missense mutation:cds:G369E (rat)
RGD
PMID:27472223
RGD:39131293
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
G
Nkx3-1
NK3 homeobox 1
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nkx3-1em1Pjhak
NK3 homeobox 1; TALEN induced mutant 1, Pjhak
IMP
compared to wild type
RGD
PMID:33368416
RGD:150573817
G
Tp53
tumor protein p53
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53em1Sage
tumor protein p53; ZFN induced mutant 1, Sage
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
G
Tmem67
transmembrane protein 67
IAGP
RGD
PMID:19515853
RGD:8554306
NCBI chr 5:25,536,458...25,589,378
Ensembl chr 5:25,536,458...25,589,334
G
Tp53
tumor protein p53
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53em1Sage
tumor protein p53; ZFN induced mutant 1, Sage
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
G
Edaradd
EDAR associated via death domain
IAGP
DNA:missense mutation:exon:p.Pro153Ser(rat)
RGD
PMID:22013926
RGD:14398762
NCBI chr17:85,866,629...85,910,612
Ensembl chr17:85,656,905...85,910,447
G
EdaraddswhKyo
EDAR-associated death domain;swh Kyo mutant
IAGP
DNA:missense mutation:exon:p.Pro153Ser(rat)
RGD
PMID:22013926
RGD:14398762
G
Tp53
tumor protein p53
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53em1Sage
tumor protein p53; ZFN induced mutant 1, Sage
IMP
compared to SD
RGD
PMID:28834365
RGD:14995504
G
Wwox
WW domain-containing oxidoreductase
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwoxlde
WW domain-containing oxidoreductase; lde mutant
IAGP
compared to wild type and heterozygotes
RGD
PMID:18676360
RGD:150429974
G
Adamts16
ADAM metallopeptidase with thrombospondin type 1 motif, 16
IMP
RGD
PMID:24983376
RGD:13434925
NCBI chr 1:32,430,436...32,562,481
Ensembl chr 1:32,430,436...32,560,494
G
Adamts16em1Bj
ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj
IMP
RGD
PMID:24983376
RGD:13434925
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:24506075
RGD:8552987
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr1em1Soar
estrogen receptor 1; ZFN induced mutant 1, Soar
IMP
RGD
PMID:24506075
RGD:8552987
G
Brca2
BRCA2, DNA repair associated
IMP
RGD
PMID:12754522
RGD:727990
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brca2m1Uwm
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison
IMP
RGD
PMID:12754522
RGD:727990
G
Dnd1
DND microRNA-mediated repression inhibitor 1
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnd1ter
DND microRNA-mediated repression inhibitor 1, ter mutant
IAGP
compared to WKY
RGD
PMID:22655094
RGD:40924659
G
Bckdk
branched chain ketoacid dehydrogenase kinase
IAGP
DNA:missense mutation:cds:G369E (rat)
RGD
PMID:27472223
RGD:39131293
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all